PDCD1 and neoplasm: Because the immunogenic cell death of tumor cells results in the activation of antitumor cytotoxic T cells [21,22], the combination of cisplatin and irradiation can potentiate the efficacy of postirradiation anti–PD-1 treatment by inducing immunogenic cell death in UC (refer to graphical abstract).